The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Advanced Strategies for Overcoming Endosomal/Lysosomal Barrier in Nanodrug Delivery
Open accessAbstract
Nanocarriers have therapeutic potential to facilitate drug delivery, including biological agents, small-molecule drugs, and nucleic acids. However, their efficiency is limited by several factors; among which, endosomal/lysosomal degradation after endocytosis is the most important. This review summarizes advanced strategies for overcoming endosomal/lysosomal barriers to efficient nanodrug delivery based on the perspective of cellular uptake and intracellular transport mechanisms. These strategies include promoting endosomal/lysosomal escape, using non-endocytic methods of delivery to directly cross the cell membrane to evade endosomes/lysosomes and making a detour pathway to evade endosomes/lysosomes. On the basis of the findings of this review, we proposed several promising strategies for overcoming endosomal/lysosomal barriers through the smarter and more efficient design of nanodrug delivery systems for future clinical applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Routes and mechanisms of extracellular vesicle uptake
Mulcahy, L. A., Pink, R. C., & Carter, D. R. F. (2014) · Journal of Extracellular Vesicles · doi:10.3402/jev.v3.24641 · Cited by 2,832 · cited 1×
“Endocytic pathways can be subdivided into CME, caveolae-mediated endocytosis (CvME), lipid raft-mediated endocytosis, MP, and membrane fusion [24,25].”
BackgroundBlock copolymer micelles in nanomedicine applications
Cabral, H., Miyata, K., Osada, K., & Kataoka, K. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00199 · Cited by 1,309 · cited 1×
“Studies have reported that the buffering capacity of some polymer-based delivery systems was insufficient to achieve endosomal escape during their transport from endosomes/lysosomes to the cytoplsm [54,102].”
BackgroundTargeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms
Akinc, A., Querbes, W., De, S., Qin, J., Frank-Kamenetsky, M., Jayaprakash, K. N., Jayaraman, M., Rajeev, K. G., Cantley, W. L., Dorkin, J. R., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.85 · Cited by 1,261
Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling
Sahay, G., Querbes, W., Alabi, C., Eltoukhy, A., Sarkar, S., Zurenko, C., Karagiannis, E., Love, K., Chen, D., Zoncu, R., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2614 · Cited by 948 · cited 1×
“Similarly, another study reported that approximately 70% of siRNA was transported to the extracellular medium by circulating endosomes through a pathway mediated by Niemann– Pick C1 within 24 h of nanoparticle uptake [21].”
BackgroundLipid nanoparticles enabling gene therapies: from concepts to clinical utility
Kulkarni, J. A., Cullis, P. R., & van der Meel, R. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2018.0721 · Cited by 592
Li, W. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.041 · Cited by 588
Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape
Endoh, T., & Ohtsuki, T. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.04.005 · Cited by 242
Metal–Phenolic Coatings as a Platform to Trigger Endosomal Escape of Nanoparticles
Chen, J., Li, J., Zhou, J., Lin, Z., Cavalieri, F., Czuba-Wojnilowicz, E., Hu, Y., Glab, A., Ju, Y., Richardson, J. J., et al. (2019) · ACS Nano · doi:10.1021/acsnano.9b05521 · Cited by 206
Challenges and opportunities to penetrate the blood-brain barrier for brain cancer therapy
Upton, D. H., Ung, C., George, S. M., Tsoli, M., Kavallaris, M., & Ziegler, D. S. (2022) · Theranostics · doi:10.7150/thno.69682 · Cited by 182
Versatile RNA Interference Nanoplatform for Systemic Delivery of RNAs
Choi, K. Y., Silvestre, O. F., Huang, X., Min, K. H., Howard, G. P., Hida, N., Jin, A. J., Carvajal, N., Lee, S. W., Hong, J.-I., et al. (2014) · ACS Nano · doi:10.1021/nn500085k · Cited by 104
Cited by
Peng, Q., Wang, S., Han, J., Huang, C., Yu, H., Li, D., Qiu, M., Cheng, S., Wu, C., Cai, M., et al. (2024) · Research · doi:10.34133/research.0339 · Cited by 89
Strategies for Small Extracellular Vesicle-Based Cancer Immunotherapy
Chen, Y., Tang, S., Cai, F., & Wan, Y. (2024) · Research · doi:10.34133/research.0421 · Cited by 26
Mitochondria transfer for myelin repair
Mozafari, S., Peruzzotti-Jametti, L., & Pluchino, S. (2026) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x251325805 · Cited by 10
“150 A recent study showed that lysosomal inhibition triggers the secretion of intact mitochondria enclosed within large EVs.”
Metadata
- Authors
- Qiu, C., Xia, F., Zhang, J., Shi, Q., Meng, Y., Wang, C., Pang, H., Gu, L., Xu, C., Guo, Q., & Wang, J.
- Venue
- Research
- Published
- 2023-01
- Volume
- 6
- Pages
- 0148-0148
- ISSN
- 2639-5274 (ISSN-L)
- OpenAlex
- W4367369083
- Cited by
- 224
- References
- 13
- FWCI
- 12.33
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Advanced Strategies for Overcoming Endosomal/Lysosomal Barrier in Nanodrug Delivery. https://app.cochat.ai/papers/10.34133/research.0148
- The paper
- Qiu, C., Xia, F., Zhang, J., Shi, Q., Meng, Y., Wang, C., Pang, H., Gu, L., Xu, C., Guo, Q., & Wang, J. (2023). Advanced Strategies for Overcoming Endosomal/Lysosomal Barrier in Nanodrug Delivery. Research. https://doi.org/10.34133/research.0148
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.